200 related articles for article (PubMed ID: 27720823)
21. Clinical relevance and public health significance of hepatitis B virus genomic variations.
Cao GW
World J Gastroenterol; 2009 Dec; 15(46):5761-9. PubMed ID: 19998495
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus sequencing and liver fibrosis evaluation in HIV/HBV co-infected Nigerians.
Grant J; Agbaji O; Kramvis A; Yousif M; Auwal M; Penugonda S; Ugoagwu P; Murphy R; Hawkins C
Trop Med Int Health; 2017 Jun; 22(6):744-754. PubMed ID: 28376292
[TBL] [Abstract][Full Text] [Related]
23. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
[TBL] [Abstract][Full Text] [Related]
24. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.
Gao ZY; Li T; Wang J; Du JM; Li YJ; Li J; Lu FM; Zhuang H
J Gastroenterol; 2007 Sep; 42(9):761-8. PubMed ID: 17876546
[TBL] [Abstract][Full Text] [Related]
25. Combination of preS deletions and A1762T/G1764A mutations in HBV subgenotype C2 increases the risk of developing HCC.
Lee MH; Kim DY; Kim JK; Chang HY; Kang SH; Ryu HJ; Ju HL; Kim SU; Lee JM; Park JY; Han KH; Chon CY; Ahn SH
Intervirology; 2012; 55(4):296-302. PubMed ID: 21865669
[TBL] [Abstract][Full Text] [Related]
26. Prevalence and molecular characterization of hepatitis B virus infection in HIV-infected children in Senegal.
Toyé RM; Lô G; Diop-Ndiaye H; Cissé AM; Ndiaye AJS; Kébé-Fall K; Dramé A; Cohen D; Pujol FH; Mboup S; Boye CS; Chemin I; Laborde-Balen G; Taverne B; Touré-Kane C
Clin Res Hepatol Gastroenterol; 2021 Mar; 45(2):101502. PubMed ID: 32828748
[TBL] [Abstract][Full Text] [Related]
27. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.
Mun HS; Lee SA; Jee Y; Kim H; Park JH; Song BC; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Kook YH; Kim BJ
J Med Virol; 2008 Jul; 80(7):1189-94. PubMed ID: 18461612
[TBL] [Abstract][Full Text] [Related]
28. Role of viral genotypes and hepatitis B viral mutants in the risk of hepatocellular carcinoma associated with hepatitis B and C dual infection.
Hung CH; Chen CH; Lee CM; Hu TH; Lu SN; Wang JH; Huang CM
Intervirology; 2013; 56(5):316-24. PubMed ID: 23838434
[TBL] [Abstract][Full Text] [Related]
29. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis B virus genotype G: prevalence and impact in patients co-infected with human immunodeficiency virus.
Dao DY; Balko J; Attar N; Neak E; Yuan HJ; Lee WM; Jain MK
J Med Virol; 2011 Sep; 83(9):1551-8. PubMed ID: 21739445
[TBL] [Abstract][Full Text] [Related]
31. Molecular epidemiology of co-infection with hepatitis B virus and human immunodeficiency virus (HIV) among adult patients in Harare, Zimbabwe.
Baudi I; Iijima S; Chin'ombe N; Mtapuri-Zinyowera S; Murakami S; Isogawa M; Hachiya A; Iwatani Y; Tanaka Y
J Med Virol; 2017 Feb; 89(2):257-266. PubMed ID: 27458715
[TBL] [Abstract][Full Text] [Related]
32. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report.
Amini-Bavil-Olyaee S; Alavian SM; Adeli A; Sarrami-Forooshani R; Sabahi F; Sabouri E; Tavangar HR; Azizi M; Mahboudi F
J Med Virol; 2006 Mar; 78(3):358-64. PubMed ID: 16419114
[TBL] [Abstract][Full Text] [Related]
34. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.
Morsica G; Ancarani F; Bagaglio S; Maracci M; Cicconi P; Cozzi Lepri A; Antonucci G; Bruno R; Santantonio T; Tacconi L; Baldelli F; Piscopo R; Santoro D; Lazzarin A; D'Arminio Monforte A;
Infection; 2009 Oct; 37(5):445-9. PubMed ID: 19669092
[TBL] [Abstract][Full Text] [Related]
35. Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
Gachara G; Magoro T; Mavhandu L; Lum E; Kimbi HK; Ndip RN; Bessong PO
AIDS Res Ther; 2017 Mar; 14(1):11. PubMed ID: 28270215
[TBL] [Abstract][Full Text] [Related]
36. Comparative analysis of HBV basic core promoter/pre-core gene mutations and viral quasispecies diversity in HIV/HBV co-infected and HBV mono-infected patients.
Deng H; Gao H; Liu Y; Xu Y; Yang J; Zhao M; Liu H; Wang Z
Acta Virol; 2022; 66(1):18-26. PubMed ID: 35380862
[TBL] [Abstract][Full Text] [Related]
37. Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
Yang HI; Yeh SH; Chen PJ; Iloeje UH; Jen CL; Su J; Wang LY; Lu SN; You SL; Chen DS; Liaw YF; Chen CJ;
J Natl Cancer Inst; 2008 Aug; 100(16):1134-43. PubMed ID: 18695135
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case-control study.
Fang ZL; Sabin CA; Dong BQ; Wei SC; Chen QY; Fang KX; Yang JY; Huang J; Wang XY; Harrison TJ
J Gen Virol; 2008 Nov; 89(Pt 11):2882-2890. PubMed ID: 18931087
[TBL] [Abstract][Full Text] [Related]
39. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment.
Zhang D; Dong P; Zhang K; Deng L; Bach C; Chen W; Li F; Protzer U; Ding H; Zeng C
BMC Microbiol; 2012 Dec; 12():307. PubMed ID: 23272650
[TBL] [Abstract][Full Text] [Related]
40. High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Jia HH; Li KW; Chen QY; Wang XY; Harrison TJ; Liang SJ; Yang QL; Wang C; Hu LP; Ren CC; Fang ZL
Intervirology; 2018; 61(3):123-132. PubMed ID: 30368502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
